Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 658.80
+2.85 (0.43%)
At close: Oct 16, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 70.05 billion as of October 16, 2026. It is the 12,112th most valuable company in the world and the 722nd biggest in India. Its market cap has increased by 336.93% in one year.
Market Cap
70.05B
Enterprise Value
68.77B
Revenue
10.05B
Global Rank
Country Rank
#722 India
PE Ratio
52.20
ChartMarket Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 70.05B, an increase of 696,785.60%. That is a compound annual growth rate of 42.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 70.05B | 305.00% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 149.58B |
| AstraZeneca Pharma India | 149.15B |
| Viyash Scientific | 98.66B |
| Procter & Gamble Health | 86.41B |
| Sanofi India | 67.75B |
| Morepen Laboratories | 67.73B |
| FDC Limited | 58.07B |
| Evonile Pharma | 46.93B |